SCHEMBL30429246

SCHEMBL30429246

CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.61
▸ IL23R Q5VWK5 4/20 0.55
▸ KEAP1 Q14145 2/20 0.55
▸ NPY4R P50391 4/20 0.54
▸ NPY1R P25929 3/20 0.54
▸ NPY2R P49146 3/20 0.54
▸ NPY5R Q15761 3/20 0.54
▸ VIPR2 P41587 2/20 0.54
▸ ECE1 P42892 1/20 0.53
▸ GLP1R P43220 1/20 0.53
▸ MUS81 Q96NY9 1/20 0.53
▸ VIPR1 P32241 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31664373 0.91 TFPI (0.68) TFPINPY4RNPY1RNPY2RNPY5R
SCHEMBL31664359 0.91 TFPI (0.68) TFPINPY4RNPY1RNPY2RNPY5R
SCHEMBL29539873 0.90 NPY4R (0.62) IL23RNPY4RNPY1RNPY2RNPY5R
SCHEMBL29770069 0.89 TFPI (0.63) TFPIIL23RKEAP1
SCHEMBL31664369 0.87 TFPI (0.64) TFPIVIPR2ECE1GLP1RMUS81
SCHEMBL30906529 0.87 IL23R (0.55) TFPIIL23R
SCHEMBL30648487 0.87 TFPI (0.61) TFPINPY4RNPY1RNPY5RVIPR2
SCHEMBL31255288 0.87 TFPI (0.61) TFPIVIPR2ECE1GLP1RMUS81
SCHEMBL30719899 0.87 TFPI (0.63) TFPINPY4RNPY1RNPY2RNPY5R
SCHEMBL30880890 0.87 NPY4R (0.54) TFPIIL23RKEAP1NPY4RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165951-A1 Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 MAMEDOV TARLAN (TR) 2023-06-01 — — US disclosed
Send feedback